Biomea Fusion Inc (BMEA)
4.50
-0.03
(-0.66%)
USD |
NASDAQ |
Jun 28, 16:00
4.42
-0.08
(-1.78%)
Pre-Market: 20:00
Biomea Fusion Free Cash Flow: -105.08M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -105.08M |
| December 31, 2023 | -99.96M |
| September 30, 2023 | -98.03M |
| June 30, 2023 | -90.84M |
| March 31, 2023 | -80.31M |
| December 31, 2022 | -63.45M |
| September 30, 2022 | -58.73M |
| Date | Value |
|---|---|
| June 30, 2022 | -53.01M |
| March 31, 2022 | -44.56M |
| December 31, 2021 | -38.61M |
| September 30, 2021 | -25.19M |
| June 30, 2021 | -15.28M |
| March 31, 2021 | -8.282M |
| December 31, 2020 | -4.459M |
Free Cash Flow Range, Past 5 Years
-105.08M
Minimum
Mar 2024
-4.459M
Maximum
Dec 2020
-56.13M
Average
-55.87M
Median
Free Cash Flow Benchmarks
| Geron Corp | -184.70M |
| Asensus Surgical Inc | -60.39M |
| Geovax Labs Inc | -27.09M |
| Syndax Pharmaceuticals Inc | -204.92M |
| Cartesian Therapeutics Inc | -58.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.03M |
| Cash from Investing (Quarterly) | -0.035M |
| Cash from Financing (Quarterly) | 0.116M |
| Free Cash Flow Per Share (Quarterly) | -0.8934 |
| Free Cash Flow Yield | -65.47% |